140 related articles for article (PubMed ID: 38731468)
1. Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics.
Gao Y; Xing S; Hu L
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731468
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism of SHP2 activation by PD-1 stimulation.
Marasco M; Berteotti A; Weyershaeuser J; Thorausch N; Sikorska J; Krausze J; Brandt HJ; Kirkpatrick J; Rios P; Schamel WW; Köhn M; Carlomagno T
Sci Adv; 2020 Jan; 6(5):eaay4458. PubMed ID: 32064351
[TBL] [Abstract][Full Text] [Related]
3.
Marasco M; Kirkpatrick JP; Carlomagno T
Biomol NMR Assign; 2020 Oct; 14(2):179-188. PubMed ID: 32236803
[TBL] [Abstract][Full Text] [Related]
4. Interaction of SHP-2 SH2 domains with PD-1 ITSM induces PD-1 dimerization and SHP-2 activation.
Patsoukis N; Duke-Cohan JS; Chaudhri A; Aksoylar HI; Wang Q; Council A; Berg A; Freeman GJ; Boussiotis VA
Commun Biol; 2020 Mar; 3(1):128. PubMed ID: 32184441
[TBL] [Abstract][Full Text] [Related]
5. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors.
Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E
Elife; 2021 Nov; 10():. PubMed ID: 34734802
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the interaction of SHP-2 with PZR, an immunoglobulin family protein containing immunoreceptor tyrosine-based inhibitory motifs.
Zhao R; Zhao ZJ
J Biol Chem; 2000 Feb; 275(8):5453-9. PubMed ID: 10681522
[TBL] [Abstract][Full Text] [Related]
7. Exploring the Allosteric Mechanism of Src Homology-2 Domain-Containing Protein Tyrosine Phosphatase 2 (SHP2) by Molecular Dynamics Simulations.
Wang Q; Zhao WC; Fu XQ; Zheng QC
Front Chem; 2020; 8():597495. PubMed ID: 33330386
[TBL] [Abstract][Full Text] [Related]
8. Immunoreceptor tyrosine-based inhibitory motif of the IL-4 receptor associates with SH2-containing phosphatases and regulates IL-4-induced proliferation.
Kashiwada M; Giallourakis CC; Pan PY; Rothman PB
J Immunol; 2001 Dec; 167(11):6382-7. PubMed ID: 11714803
[TBL] [Abstract][Full Text] [Related]
9. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.
Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK
Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871
[TBL] [Abstract][Full Text] [Related]
10. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
[TBL] [Abstract][Full Text] [Related]
11. Uncoupling ITIM receptor G6b-B from tyrosine phosphatases Shp1 and Shp2 disrupts murine platelet homeostasis.
Geer MJ; van Geffen JP; Gopalasingam P; Vögtle T; Smith CW; Heising S; Kuijpers MJE; Tullemans BME; Jarvis GE; Eble JA; Jeeves M; Overduin M; Heemskerk JWM; Mazharian A; Senis YA
Blood; 2018 Sep; 132(13):1413-1425. PubMed ID: 29891536
[TBL] [Abstract][Full Text] [Related]
12. An auxiliary binding interface of SHIP2-SH2 for Y292-phosphorylated FcγRIIB reveals diverse recognition mechanisms for tyrosine-phosphorylated receptors involved in different cell signaling pathways.
Wang Z; Zhou H; Yue X; Zhu J; Yang Y; Liu M
Anal Bioanal Chem; 2022 Jan; 414(1):497-506. PubMed ID: 34021368
[TBL] [Abstract][Full Text] [Related]
13. Molecular recognition of ITIM/ITSM domains with SHP2 and their allosteric effect.
Cheng Y; Ouyang W; Liu L; Tang L; Zhang Z; Yue X; Liang L; Hu J; Luo T
Phys Chem Chem Phys; 2024 Mar; 26(12):9155-9169. PubMed ID: 38165855
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation and localization of protein-zero related (PZR) in cultured endothelial cells.
Kusano K; Thomas TN; Fujiwara K
Endothelium; 2008; 15(3):127-36. PubMed ID: 18568953
[TBL] [Abstract][Full Text] [Related]
15. Fc gamma receptor type IIb induced recruitment of inositol and protein phosphatases to the signal transductory complex of human B-cell.
Sarmay G; Koncz G; Pecht I; Gergely J
Immunol Lett; 1997 Jun; 57(1-3):159-64. PubMed ID: 9232445
[TBL] [Abstract][Full Text] [Related]
16. Effects of Src homology domain 2 (SH2)-containing inositol phosphatase (SHIP), SH2-containing phosphotyrosine phosphatase (SHP)-1, and SHP-2 SH2 decoy proteins on Fc gamma RIIB1-effector interactions and inhibitory functions.
Nakamura K; Brauweiler A; Cambier JC
J Immunol; 2000 Jan; 164(2):631-8. PubMed ID: 10623804
[TBL] [Abstract][Full Text] [Related]
17. Dissection of the BCR-ABL signaling network using highly specific monobody inhibitors to the SHP2 SH2 domains.
Sha F; Gencer EB; Georgeon S; Koide A; Yasui N; Koide S; Hantschel O
Proc Natl Acad Sci U S A; 2013 Sep; 110(37):14924-9. PubMed ID: 23980151
[TBL] [Abstract][Full Text] [Related]
18. Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2.
Cheng H; Schwell V; Curtis BR; Fazlieva R; Roder H; Campbell KS
Structure; 2019 Apr; 27(4):639-650.e2. PubMed ID: 30773397
[TBL] [Abstract][Full Text] [Related]
19. SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
Yusa S; Catina TL; Campbell KS
J Immunol; 2002 May; 168(10):5047-57. PubMed ID: 11994457
[TBL] [Abstract][Full Text] [Related]
20. Co-clustering of Fcgamma and B cell receptors induces dephosphorylation of the Grb2-associated binder 1 docking protein.
Koncz G; Tóth GK; Bökönyi G; Kéri G; Pecht I; Medgyesi D; Gergely J; Sármay G
Eur J Biochem; 2001 Jul; 268(14):3898-906. PubMed ID: 11453982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
